PubMed:10460835
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 54-60 | Glycan_Motif | denotes | core-2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
| T2 | 1071-1077 | Glycan_Motif | denotes | core-2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 474-492 | HP_0002894 | denotes | tumoral pancreatic |
| T2 | 474-481 | HP_0002664 | denotes | tumoral |
| T3 | 514-532 | HP_0002894 | denotes | pancreatic tumoral |
| T4 | 525-532 | HP_0002664 | denotes | tumoral |
| T5 | 961-979 | HP_0002894 | denotes | pancreatic tumoral |
| T6 | 972-979 | HP_0002664 | denotes | tumoral |
| T7 | 1325-1330 | HP_0002664 | denotes | tumor |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 170-177 | FMAID:165447 | denotes | protein |
| _T2 | 170-177 | FMAID:67257 | denotes | protein |
| _T3 | 217-221 | FMAID:167334 | denotes | bile |
| _T4 | 493-500 | FMAID:256050 | denotes | tissues |
| _T5 | 569-574 | FMAID:169002 | denotes | cells |
| _T6 | 569-574 | FMAID:68646 | denotes | cells |
| _T7 | 636-643 | FMAID:256050 | denotes | tissues |
| _T8 | 672-677 | FMAID:68646 | denotes | cells |
| _T9 | 672-677 | FMAID:169002 | denotes | cells |
| _T10 | 1010-1017 | FMAID:256050 | denotes | tissues |
| _T11 | 1216-1222 | FMAID:178661 | denotes | tested |
| _T12 | 1331-1336 | FMAID:68646 | denotes | cells |
| _T13 | 1331-1336 | FMAID:169002 | denotes | cells |
| _T14 | 1463-1468 | FMAID:169002 | denotes | cells |
| _T15 | 1463-1468 | FMAID:68646 | denotes | cells |
| _T16 | 1533-1537 | FMAID:216818 | denotes | gain |
| _T17 | 1773-1778 | FMAID:169002 | denotes | cells |
| _T18 | 1773-1778 | FMAID:68646 | denotes | cells |
| _T19 | 1950-1955 | FMAID:68646 | denotes | cells |
| _T20 | 1950-1955 | FMAID:169002 | denotes | cells |
| _T21 | 2085-2093 | FMAID:167180 | denotes | antibody |
| _T22 | 2286-2291 | FMAID:169002 | denotes | cells |
| _T23 | 2286-2291 | FMAID:68646 | denotes | cells |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 67-98 | http://www.uniprot.org/uniprot/Q06430 | denotes | N-acetylglucosaminyltransferase |
| T2 | 1084-1115 | http://www.uniprot.org/uniprot/Q06430 | denotes | N-acetylglucosaminyltransferase |
| T3 | 67-98 | http://www.uniprot.org/uniprot/Q8N0V5 | denotes | N-acetylglucosaminyltransferase |
| T4 | 1084-1115 | http://www.uniprot.org/uniprot/Q8N0V5 | denotes | N-acetylglucosaminyltransferase |
| T5 | 67-98 | http://www.uniprot.org/uniprot/Q8NFS9 | denotes | N-acetylglucosaminyltransferase |
| T6 | 1084-1115 | http://www.uniprot.org/uniprot/Q8NFS9 | denotes | N-acetylglucosaminyltransferase |
| T7 | 110-130 | http://www.uniprot.org/uniprot/P22083 | denotes | 4-fucosyltransferase |
| T8 | 1282-1291 | http://www.uniprot.org/uniprot/P13674 | denotes | alpha(1-4 |
| T9 | 1691-1693 | http://www.uniprot.org/uniprot/P04264 | denotes | K1 |
| T10 | 1770-1772 | http://www.uniprot.org/uniprot/P04264 | denotes | K1 |
| T11 | 2283-2285 | http://www.uniprot.org/uniprot/P04264 | denotes | K1 |
| T12 | 1731-1735 | http://www.uniprot.org/uniprot/P21217 | denotes | FUT3 |
| T13 | 1856-1860 | http://www.uniprot.org/uniprot/P21217 | denotes | FUT3 |
| T14 | 2060-2064 | http://www.uniprot.org/uniprot/P21217 | denotes | FUT3 |
| T15 | 2139-2143 | http://www.uniprot.org/uniprot/P21217 | denotes | FUT3 |
| T16 | 2414-2418 | http://www.uniprot.org/uniprot/P21217 | denotes | FUT3 |
| T17 | 2564-2568 | http://www.uniprot.org/uniprot/P21217 | denotes | FUT3 |
| T18 | 1743-1747 | http://www.uniprot.org/uniprot/Q11130 | denotes | FUT7 |
| T19 | 1868-1872 | http://www.uniprot.org/uniprot/Q11130 | denotes | FUT7 |
| T20 | 2147-2151 | http://www.uniprot.org/uniprot/Q11130 | denotes | FUT7 |
| T21 | 1898-1916 | http://www.uniprot.org/uniprot/Q6FHM1 | denotes | C-terminal peptide |
| T22 | 2217-2235 | http://www.uniprot.org/uniprot/Q6FHM1 | denotes | C-terminal peptide |
| T23 | 1898-1916 | http://www.uniprot.org/uniprot/Q9Y287 | denotes | C-terminal peptide |
| T24 | 2217-2235 | http://www.uniprot.org/uniprot/Q9Y287 | denotes | C-terminal peptide |
| T25 | 1898-1916 | http://www.uniprot.org/uniprot/P05408 | denotes | C-terminal peptide |
| T26 | 2217-2235 | http://www.uniprot.org/uniprot/P05408 | denotes | C-terminal peptide |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 67-98 | http://www.uniprot.org/uniprot/P97402 | denotes | N-acetylglucosaminyltransferase |
| T2 | 1084-1115 | http://www.uniprot.org/uniprot/P97402 | denotes | N-acetylglucosaminyltransferase |
| T3 | 110-130 | http://www.uniprot.org/uniprot/Q11127 | denotes | 4-fucosyltransferase |
| T4 | 1691-1693 | http://www.uniprot.org/uniprot/P04104 | denotes | K1 |
| T5 | 1770-1772 | http://www.uniprot.org/uniprot/P04104 | denotes | K1 |
| T6 | 2283-2285 | http://www.uniprot.org/uniprot/P04104 | denotes | K1 |
| T7 | 1898-1916 | http://www.uniprot.org/uniprot/O89051 | denotes | C-terminal peptide |
| T8 | 2217-2235 | http://www.uniprot.org/uniprot/O89051 | denotes | C-terminal peptide |
| T9 | 1898-1916 | http://www.uniprot.org/uniprot/P10601 | denotes | C-terminal peptide |
| T10 | 2217-2235 | http://www.uniprot.org/uniprot/P10601 | denotes | C-terminal peptide |
| T11 | 1898-1916 | http://www.uniprot.org/uniprot/P12961 | denotes | C-terminal peptide |
| T12 | 2217-2235 | http://www.uniprot.org/uniprot/P12961 | denotes | C-terminal peptide |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 493-500 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T2 | 569-574 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T3 | 636-643 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T4 | 672-677 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T5 | 702-706 | http://purl.bioontology.org/ontology/NCBITAXON/9973 | denotes | many |
| T6 | 1010-1017 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T7 | 1331-1336 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T8 | 1463-1468 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T9 | 1773-1778 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T10 | 1950-1955 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T11 | 2286-2291 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-142 | Sentence | denotes | The formation of the oncofetal J28 glycotope involves core-2 beta6-N-acetylglucosaminyltransferase and alpha3/4-fucosyltransferase activities. |
| TextSentencer_T2 | 143-327 | Sentence | denotes | The feto-acinar pancreatic protein or FAPP, the oncofetal glycoisoform of bile salt-dependent lipase (BSDL), is characterized by the presence of the J28 glycotope recognized by mAbJ28. |
| TextSentencer_T3 | 328-436 | Sentence | denotes | This fucosylated epitope is carried out by the O-linked glycans of the C-terminal mucin-like region of BSDL. |
| TextSentencer_T4 | 437-575 | Sentence | denotes | This glycotope is expressed by human tumoral pancreatic tissues and by human pancreatic tumoral cell lines such as SOJ-6 and BxPC-3 cells. |
| TextSentencer_T5 | 576-678 | Sentence | denotes | However, it is not expressed by the normal human pancreatic tissues and by MiaPaCa-2 and Panc-1 cells. |
| TextSentencer_T6 | 679-844 | Sentence | denotes | Due to the presence of many putative sites for O-glycosylation on FAPP and BSDL, the structure of the J28 glycotope cannot be attained by classical physical methods. |
| TextSentencer_T7 | 845-1132 | Sentence | denotes | In the first part of the present study, we have determined which glycosyltransferases were differently expressed in pancreatic tumoral cell lines compared to normal tissues, focusing in part on fucosyltransferases (Fuc-T) and core-2 beta6-N-acetylglucosaminyltransferase (Core2GlcNAc-T). |
| TextSentencer_T8 | 1133-1262 | Sentence | denotes | Our data suggested that alpha2-Fuc-T activity was decreased in the four cell lines tested (SOJ-6, BxPC-3, MiaPaCa-2, and Panc-1). |
| TextSentencer_T9 | 1263-1508 | Sentence | denotes | The alpha(1-3) and alpha(1-4) fucosylations were decreased in tumor cells that do not express the J28 glycotope whereas alpha4-Fuc-T and Core2GlcNAc-T activities were significantly increased in SOJ-6 cells which best expressed the J28 glycotope. |
| TextSentencer_T10 | 1509-1759 | Sentence | denotes | Therefore, we wished to gain information about glycosyltransferases involved in the building of this structure by transfecting the cDNA encoding the mucin-like region of BSDL in CHO-K1 also expressing Core2GlcNAc-T and/or FUT3 and/or FUT7 activities. |
| TextSentencer_T11 | 1760-1873 | Sentence | denotes | These CHO-K1 cells have been previously transfected with the cDNA encoding Core2GlcNAc-T and/or FUT3 and/or FUT7. |
| TextSentencer_T12 | 1874-2033 | Sentence | denotes | Data indicated that the C-terminal peptide of BSDL (Cter) produced by those cells did not carry out the J28 glycotope unless Core2GlcNAc-T activity is present. |
| TextSentencer_T13 | 2034-2106 | Sentence | denotes | Further transfection with FUT3 cDNA, increased the antibody recognition. |
| TextSentencer_T14 | 2107-2236 | Sentence | denotes | Nevertheless, transfection with FUT3 or FUT7 alone did not generate the formation of the J28 glycotope on the C-terminal peptide. |
| TextSentencer_T15 | 2237-2419 | Sentence | denotes | Furthermore, the Cter peptide produced by CHO-K1 cells expressing Core2GlcNAc-T was more reactive to the mAbJ28 after in vitro fucosylation with the recombinant soluble form of FUT3. |
| TextSentencer_T16 | 2420-2596 | Sentence | denotes | These data suggested that the J28 glycotope encompasses structures initiated by Core2GlcNAc-T and further fucosylated by alpha3/4-Fuc-T such as FUT3, likely on GlcNAc residues. |
| T1 | 0-142 | Sentence | denotes | The formation of the oncofetal J28 glycotope involves core-2 beta6-N-acetylglucosaminyltransferase and alpha3/4-fucosyltransferase activities. |
| T2 | 143-327 | Sentence | denotes | The feto-acinar pancreatic protein or FAPP, the oncofetal glycoisoform of bile salt-dependent lipase (BSDL), is characterized by the presence of the J28 glycotope recognized by mAbJ28. |
| T3 | 328-436 | Sentence | denotes | This fucosylated epitope is carried out by the O-linked glycans of the C-terminal mucin-like region of BSDL. |
| T4 | 437-575 | Sentence | denotes | This glycotope is expressed by human tumoral pancreatic tissues and by human pancreatic tumoral cell lines such as SOJ-6 and BxPC-3 cells. |
| T5 | 576-678 | Sentence | denotes | However, it is not expressed by the normal human pancreatic tissues and by MiaPaCa-2 and Panc-1 cells. |
| T6 | 679-844 | Sentence | denotes | Due to the presence of many putative sites for O-glycosylation on FAPP and BSDL, the structure of the J28 glycotope cannot be attained by classical physical methods. |
| T7 | 845-1132 | Sentence | denotes | In the first part of the present study, we have determined which glycosyltransferases were differently expressed in pancreatic tumoral cell lines compared to normal tissues, focusing in part on fucosyltransferases (Fuc-T) and core-2 beta6-N-acetylglucosaminyltransferase (Core2GlcNAc-T). |
| T8 | 1133-1262 | Sentence | denotes | Our data suggested that alpha2-Fuc-T activity was decreased in the four cell lines tested (SOJ-6, BxPC-3, MiaPaCa-2, and Panc-1). |
| T9 | 1263-1508 | Sentence | denotes | The alpha(1-3) and alpha(1-4) fucosylations were decreased in tumor cells that do not express the J28 glycotope whereas alpha4-Fuc-T and Core2GlcNAc-T activities were significantly increased in SOJ-6 cells which best expressed the J28 glycotope. |
| T10 | 1509-1759 | Sentence | denotes | Therefore, we wished to gain information about glycosyltransferases involved in the building of this structure by transfecting the cDNA encoding the mucin-like region of BSDL in CHO-K1 also expressing Core2GlcNAc-T and/or FUT3 and/or FUT7 activities. |
| T11 | 1760-1873 | Sentence | denotes | These CHO-K1 cells have been previously transfected with the cDNA encoding Core2GlcNAc-T and/or FUT3 and/or FUT7. |
| T12 | 1874-2033 | Sentence | denotes | Data indicated that the C-terminal peptide of BSDL (Cter) produced by those cells did not carry out the J28 glycotope unless Core2GlcNAc-T activity is present. |
| T13 | 2034-2106 | Sentence | denotes | Further transfection with FUT3 cDNA, increased the antibody recognition. |
| T14 | 2107-2236 | Sentence | denotes | Nevertheless, transfection with FUT3 or FUT7 alone did not generate the formation of the J28 glycotope on the C-terminal peptide. |
| T15 | 2237-2419 | Sentence | denotes | Furthermore, the Cter peptide produced by CHO-K1 cells expressing Core2GlcNAc-T was more reactive to the mAbJ28 after in vitro fucosylation with the recombinant soluble form of FUT3. |
| T16 | 2420-2596 | Sentence | denotes | These data suggested that the J28 glycotope encompasses structures initiated by Core2GlcNAc-T and further fucosylated by alpha3/4-Fuc-T such as FUT3, likely on GlcNAc residues. |
| T1 | 0-142 | Sentence | denotes | The formation of the oncofetal J28 glycotope involves core-2 beta6-N-acetylglucosaminyltransferase and alpha3/4-fucosyltransferase activities. |
| T2 | 143-327 | Sentence | denotes | The feto-acinar pancreatic protein or FAPP, the oncofetal glycoisoform of bile salt-dependent lipase (BSDL), is characterized by the presence of the J28 glycotope recognized by mAbJ28. |
| T3 | 328-436 | Sentence | denotes | This fucosylated epitope is carried out by the O-linked glycans of the C-terminal mucin-like region of BSDL. |
| T4 | 437-575 | Sentence | denotes | This glycotope is expressed by human tumoral pancreatic tissues and by human pancreatic tumoral cell lines such as SOJ-6 and BxPC-3 cells. |
| T5 | 576-678 | Sentence | denotes | However, it is not expressed by the normal human pancreatic tissues and by MiaPaCa-2 and Panc-1 cells. |
| T6 | 679-844 | Sentence | denotes | Due to the presence of many putative sites for O-glycosylation on FAPP and BSDL, the structure of the J28 glycotope cannot be attained by classical physical methods. |
| T7 | 845-1132 | Sentence | denotes | In the first part of the present study, we have determined which glycosyltransferases were differently expressed in pancreatic tumoral cell lines compared to normal tissues, focusing in part on fucosyltransferases (Fuc-T) and core-2 beta6-N-acetylglucosaminyltransferase (Core2GlcNAc-T). |
| T8 | 1133-1262 | Sentence | denotes | Our data suggested that alpha2-Fuc-T activity was decreased in the four cell lines tested (SOJ-6, BxPC-3, MiaPaCa-2, and Panc-1). |
| T9 | 1263-1508 | Sentence | denotes | The alpha(1-3) and alpha(1-4) fucosylations were decreased in tumor cells that do not express the J28 glycotope whereas alpha4-Fuc-T and Core2GlcNAc-T activities were significantly increased in SOJ-6 cells which best expressed the J28 glycotope. |
| T10 | 1509-1759 | Sentence | denotes | Therefore, we wished to gain information about glycosyltransferases involved in the building of this structure by transfecting the cDNA encoding the mucin-like region of BSDL in CHO-K1 also expressing Core2GlcNAc-T and/or FUT3 and/or FUT7 activities. |
| T11 | 1760-1873 | Sentence | denotes | These CHO-K1 cells have been previously transfected with the cDNA encoding Core2GlcNAc-T and/or FUT3 and/or FUT7. |
| T12 | 1874-2033 | Sentence | denotes | Data indicated that the C-terminal peptide of BSDL (Cter) produced by those cells did not carry out the J28 glycotope unless Core2GlcNAc-T activity is present. |
| T13 | 2034-2106 | Sentence | denotes | Further transfection with FUT3 cDNA, increased the antibody recognition. |
| T14 | 2107-2236 | Sentence | denotes | Nevertheless, transfection with FUT3 or FUT7 alone did not generate the formation of the J28 glycotope on the C-terminal peptide. |
| T15 | 2237-2419 | Sentence | denotes | Furthermore, the Cter peptide produced by CHO-K1 cells expressing Core2GlcNAc-T was more reactive to the mAbJ28 after in vitro fucosylation with the recombinant soluble form of FUT3. |
| T16 | 2420-2596 | Sentence | denotes | These data suggested that the J28 glycotope encompasses structures initiated by Core2GlcNAc-T and further fucosylated by alpha3/4-Fuc-T such as FUT3, likely on GlcNAc residues. |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-13 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
| T2 | 2179-2188 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
| T3 | 112-141 | http://purl.obolibrary.org/obo/GO_0008417 | denotes | fucosyltransferase activities |
| T4 | 333-344 | http://purl.obolibrary.org/obo/GO_0036065 | denotes | fucosylated |
| T5 | 1293-1306 | http://purl.obolibrary.org/obo/GO_0036065 | denotes | fucosylations |
| T6 | 2364-2376 | http://purl.obolibrary.org/obo/GO_0036065 | denotes | fucosylation |
| T7 | 728-741 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T8 | 1687-1690 | http://purl.obolibrary.org/obo/GO_0043848 | denotes | CHO |
| T9 | 1766-1769 | http://purl.obolibrary.org/obo/GO_0043848 | denotes | CHO |
| T10 | 2279-2282 | http://purl.obolibrary.org/obo/GO_0043848 | denotes | CHO |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 2085-2093 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 54-58 | http://purl.obolibrary.org/obo/GO_0019013 | denotes | core |
| T2 | 1071-1075 | http://purl.obolibrary.org/obo/GO_0019013 | denotes | core |
| T3 | 533-537 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T4 | 980-984 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T5 | 569-574 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T6 | 672-677 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T7 | 1331-1336 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T8 | 1463-1468 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T9 | 1773-1778 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T10 | 1950-1955 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T11 | 2286-2291 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 217-221 | http://purl.obolibrary.org/obo/UBERON_0001970 | denotes | bile |
| T2 | 493-500 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T3 | 636-643 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T4 | 1010-1017 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
EDAM-topics
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 170-177 | http://edamontology.org/topic_0078 | denotes | protein |
| T2 | 401-409 | http://edamontology.org/topic_0749 | denotes | terminal |
| T3 | 468-473 | http://edamontology.org/topic_2815 | denotes | human |
| T4 | 508-513 | http://edamontology.org/topic_2815 | denotes | human |
| T5 | 619-624 | http://edamontology.org/topic_2815 | denotes | human |
| T6 | 827-835 | http://edamontology.org/topic_3318 | denotes | physical |
| T7 | 878-883 | http://edamontology.org/topic_3678 | denotes | study |
| T8 | 1640-1644 | http://edamontology.org/topic_3512 | denotes | cDNA |
| T9 | 1821-1825 | http://edamontology.org/topic_3512 | denotes | cDNA |
| T10 | 1900-1908 | http://edamontology.org/topic_0749 | denotes | terminal |
| T11 | 1909-1916 | http://edamontology.org/topic_0154 | denotes | peptide |
| T12 | 2065-2069 | http://edamontology.org/topic_3512 | denotes | cDNA |
| T13 | 2219-2227 | http://edamontology.org/topic_0749 | denotes | terminal |
| T14 | 2228-2235 | http://edamontology.org/topic_0154 | denotes | peptide |
| T15 | 2259-2266 | http://edamontology.org/topic_0154 | denotes | peptide |
EDAM-DFO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-13 | http://edamontology.org/format_1915 | denotes | formation |
| T2 | 4-13 | http://edamontology.org/operation_0335 | denotes | formation |
| T3 | 170-177 | http://edamontology.org/format_1208 | denotes | protein |
| T4 | 170-177 | http://edamontology.org/data_1467 | denotes | protein |
| T5 | 612-618 | http://edamontology.org/operation_3435 | denotes | normal |
| T6 | 764-773 | http://edamontology.org/data_0883 | denotes | structure |
| T7 | 1003-1009 | http://edamontology.org/operation_3435 | denotes | normal |
| T8 | 1137-1141 | http://edamontology.org/data_0006 | denotes | data |
| T9 | 1610-1619 | http://edamontology.org/data_0883 | denotes | structure |
| T10 | 1874-1878 | http://edamontology.org/data_0006 | denotes | Data |
| T11 | 1909-1916 | http://edamontology.org/data_2906 | denotes | peptide |
| T12 | 2094-2105 | http://edamontology.org/operation_2423 | denotes | recognition |
| T13 | 2166-2174 | http://edamontology.org/operation_3429 | denotes | generate |
| T14 | 2179-2188 | http://edamontology.org/format_1915 | denotes | formation |
| T15 | 2179-2188 | http://edamontology.org/operation_0335 | denotes | formation |
| T16 | 2228-2235 | http://edamontology.org/data_2906 | denotes | peptide |
| T17 | 2259-2266 | http://edamontology.org/data_2906 | denotes | peptide |
| T18 | 2426-2430 | http://edamontology.org/data_0006 | denotes | data |
| T19 | 2476-2486 | http://edamontology.org/data_0883 | denotes | structures |
| T20 | 2587-2595 | http://edamontology.org/data_1756 | denotes | residues |
NGLY1-deficiency
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-NGLY1-deficiency-B_T1 | 2580-2586 | chem:24139 | denotes | GlcNAc |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 493-500 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T2 | 636-643 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T3 | 1010-1017 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T4 | 217-221 | http://purl.obolibrary.org/obo/UBERON_0001970 | denotes | bile |
GlyTouCan-IUPAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| GlycanIUPAC_T1 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G49112ZN" | denotes | Fuc |
| GlycanIUPAC_T2 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G49112ZN" | denotes | Fuc |
| GlycanIUPAC_T3 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G49112ZN" | denotes | Fuc |
| GlycanIUPAC_T4 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G49112ZN" | denotes | Fuc |
| GlycanIUPAC_T5 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G50059AJ" | denotes | Fuc |
| GlycanIUPAC_T6 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G50059AJ" | denotes | Fuc |
| GlycanIUPAC_T7 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G50059AJ" | denotes | Fuc |
| GlycanIUPAC_T8 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G50059AJ" | denotes | Fuc |
| GlycanIUPAC_T9 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G76218YK" | denotes | Fuc |
| GlycanIUPAC_T10 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G76218YK" | denotes | Fuc |
| GlycanIUPAC_T11 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G76218YK" | denotes | Fuc |
| GlycanIUPAC_T12 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G76218YK" | denotes | Fuc |
| GlycanIUPAC_T13 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G50102KR" | denotes | Fuc |
| GlycanIUPAC_T14 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G50102KR" | denotes | Fuc |
| GlycanIUPAC_T15 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G50102KR" | denotes | Fuc |
| GlycanIUPAC_T16 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G50102KR" | denotes | Fuc |
| GlycanIUPAC_T17 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G10717VS" | denotes | Fuc |
| GlycanIUPAC_T18 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G10717VS" | denotes | Fuc |
| GlycanIUPAC_T19 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G10717VS" | denotes | Fuc |
| GlycanIUPAC_T20 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G10717VS" | denotes | Fuc |
| GlycanIUPAC_T21 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G60524RK" | denotes | Fuc |
| GlycanIUPAC_T22 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G60524RK" | denotes | Fuc |
| GlycanIUPAC_T23 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G60524RK" | denotes | Fuc |
| GlycanIUPAC_T24 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G60524RK" | denotes | Fuc |
| GlycanIUPAC_T25 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G84407TT" | denotes | Fuc |
| GlycanIUPAC_T26 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G84407TT" | denotes | Fuc |
| GlycanIUPAC_T27 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G84407TT" | denotes | Fuc |
| GlycanIUPAC_T28 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G84407TT" | denotes | Fuc |
| GlycanIUPAC_T29 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G64717JT" | denotes | Fuc |
| GlycanIUPAC_T30 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G64717JT" | denotes | Fuc |
| GlycanIUPAC_T31 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G64717JT" | denotes | Fuc |
| GlycanIUPAC_T32 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G64717JT" | denotes | Fuc |
| GlycanIUPAC_T33 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G45003TT" | denotes | Fuc |
| GlycanIUPAC_T34 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G45003TT" | denotes | Fuc |
| GlycanIUPAC_T35 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G45003TT" | denotes | Fuc |
| GlycanIUPAC_T36 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G45003TT" | denotes | Fuc |
| GlycanIUPAC_T37 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G73923FP" | denotes | Fuc |
| GlycanIUPAC_T38 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G73923FP" | denotes | Fuc |
| GlycanIUPAC_T39 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G73923FP" | denotes | Fuc |
| GlycanIUPAC_T40 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G73923FP" | denotes | Fuc |
| GlycanIUPAC_T41 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G78231MB" | denotes | Fuc |
| GlycanIUPAC_T42 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G78231MB" | denotes | Fuc |
| GlycanIUPAC_T43 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G78231MB" | denotes | Fuc |
| GlycanIUPAC_T44 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G78231MB" | denotes | Fuc |
| GlycanIUPAC_T45 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G80487UG" | denotes | Fuc |
| GlycanIUPAC_T46 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G80487UG" | denotes | Fuc |
| GlycanIUPAC_T47 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G80487UG" | denotes | Fuc |
| GlycanIUPAC_T48 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G80487UG" | denotes | Fuc |
| GlycanIUPAC_T49 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G29758MI" | denotes | Fuc |
| GlycanIUPAC_T50 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G29758MI" | denotes | Fuc |
| GlycanIUPAC_T51 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G29758MI" | denotes | Fuc |
| GlycanIUPAC_T52 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G29758MI" | denotes | Fuc |
| GlycanIUPAC_T53 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G02671KD" | denotes | Fuc |
| GlycanIUPAC_T54 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G02671KD" | denotes | Fuc |
| GlycanIUPAC_T55 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G02671KD" | denotes | Fuc |
| GlycanIUPAC_T56 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G02671KD" | denotes | Fuc |
| GlycanIUPAC_T57 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G57926TZ" | denotes | Fuc |
| GlycanIUPAC_T58 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G57926TZ" | denotes | Fuc |
| GlycanIUPAC_T59 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G57926TZ" | denotes | Fuc |
| GlycanIUPAC_T60 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G57926TZ" | denotes | Fuc |
| GlycanIUPAC_T61 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G41718FD" | denotes | Fuc |
| GlycanIUPAC_T62 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G41718FD" | denotes | Fuc |
| GlycanIUPAC_T63 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G41718FD" | denotes | Fuc |
| GlycanIUPAC_T64 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G41718FD" | denotes | Fuc |
| GlycanIUPAC_T65 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G99840FL" | denotes | Fuc |
| GlycanIUPAC_T66 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G99840FL" | denotes | Fuc |
| GlycanIUPAC_T67 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G99840FL" | denotes | Fuc |
| GlycanIUPAC_T68 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G99840FL" | denotes | Fuc |
| GlycanIUPAC_T69 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G64321UX" | denotes | Fuc |
| GlycanIUPAC_T70 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G64321UX" | denotes | Fuc |
| GlycanIUPAC_T71 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G64321UX" | denotes | Fuc |
| GlycanIUPAC_T72 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G64321UX" | denotes | Fuc |
| GlycanIUPAC_T73 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G11231EG" | denotes | Fuc |
| GlycanIUPAC_T74 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G11231EG" | denotes | Fuc |
| GlycanIUPAC_T75 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G11231EG" | denotes | Fuc |
| GlycanIUPAC_T76 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G11231EG" | denotes | Fuc |
| GlycanIUPAC_T77 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G62741TN" | denotes | Fuc |
| GlycanIUPAC_T78 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G62741TN" | denotes | Fuc |
| GlycanIUPAC_T79 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G62741TN" | denotes | Fuc |
| GlycanIUPAC_T80 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G62741TN" | denotes | Fuc |
| GlycanIUPAC_T81 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G51576ZQ" | denotes | Fuc |
| GlycanIUPAC_T82 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G51576ZQ" | denotes | Fuc |
| GlycanIUPAC_T83 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G51576ZQ" | denotes | Fuc |
| GlycanIUPAC_T84 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G51576ZQ" | denotes | Fuc |
| GlycanIUPAC_T85 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G66056LD" | denotes | Fuc |
| GlycanIUPAC_T86 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G66056LD" | denotes | Fuc |
| GlycanIUPAC_T87 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G66056LD" | denotes | Fuc |
| GlycanIUPAC_T88 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G66056LD" | denotes | Fuc |
| GlycanIUPAC_T89 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G02768BF" | denotes | Fuc |
| GlycanIUPAC_T90 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G02768BF" | denotes | Fuc |
| GlycanIUPAC_T91 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G02768BF" | denotes | Fuc |
| GlycanIUPAC_T92 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G02768BF" | denotes | Fuc |
| GlycanIUPAC_T93 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G26168RO" | denotes | Fuc |
| GlycanIUPAC_T94 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G26168RO" | denotes | Fuc |
| GlycanIUPAC_T95 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G26168RO" | denotes | Fuc |
| GlycanIUPAC_T96 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G26168RO" | denotes | Fuc |
| GlycanIUPAC_T97 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G42890HL" | denotes | Fuc |
| GlycanIUPAC_T98 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G42890HL" | denotes | Fuc |
| GlycanIUPAC_T99 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G42890HL" | denotes | Fuc |
| GlycanIUPAC_T100 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G42890HL" | denotes | Fuc |
| GlycanIUPAC_T101 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G17533VU" | denotes | Fuc |
| GlycanIUPAC_T102 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G17533VU" | denotes | Fuc |
| GlycanIUPAC_T103 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G17533VU" | denotes | Fuc |
| GlycanIUPAC_T104 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G17533VU" | denotes | Fuc |
| GlycanIUPAC_T105 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G34306RG" | denotes | Fuc |
| GlycanIUPAC_T106 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G34306RG" | denotes | Fuc |
| GlycanIUPAC_T107 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G34306RG" | denotes | Fuc |
| GlycanIUPAC_T108 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G34306RG" | denotes | Fuc |
| GlycanIUPAC_T109 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G88735KU" | denotes | Fuc |
| GlycanIUPAC_T110 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G88735KU" | denotes | Fuc |
| GlycanIUPAC_T111 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G88735KU" | denotes | Fuc |
| GlycanIUPAC_T112 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G88735KU" | denotes | Fuc |
| GlycanIUPAC_T113 | 1060-1063 | "http://rdf.glycoinfo.org/glycan/G82605UA" | denotes | Fuc |
| GlycanIUPAC_T114 | 1164-1167 | "http://rdf.glycoinfo.org/glycan/G82605UA" | denotes | Fuc |
| GlycanIUPAC_T115 | 1390-1393 | "http://rdf.glycoinfo.org/glycan/G82605UA" | denotes | Fuc |
| GlycanIUPAC_T116 | 2550-2553 | "http://rdf.glycoinfo.org/glycan/G82605UA" | denotes | Fuc |
| GlycanIUPAC_T117 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G26693XF" | denotes | GlcNAc |
| GlycanIUPAC_T118 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G01864SU" | denotes | GlcNAc |
| GlycanIUPAC_T119 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G17605FD" | denotes | GlcNAc |
| GlycanIUPAC_T120 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G41950LU" | denotes | GlcNAc |
| GlycanIUPAC_T121 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G57195RJ" | denotes | GlcNAc |
| GlycanIUPAC_T122 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G85391SA" | denotes | GlcNAc |
| GlycanIUPAC_T123 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G89565QL" | denotes | GlcNAc |
| GlycanIUPAC_T124 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G80869MR" | denotes | GlcNAc |
| GlycanIUPAC_T125 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G55978NL" | denotes | GlcNAc |
| GlycanIUPAC_T126 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G54644LT" | denotes | GlcNAc |
| GlycanIUPAC_T127 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G25694UG" | denotes | GlcNAc |
| GlycanIUPAC_T128 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G25126RB" | denotes | GlcNAc |
| GlycanIUPAC_T129 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G51848AD" | denotes | GlcNAc |
| GlycanIUPAC_T130 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G94667GM" | denotes | GlcNAc |
| GlycanIUPAC_T131 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G30124BO" | denotes | GlcNAc |
| GlycanIUPAC_T132 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G82777EZ" | denotes | GlcNAc |
| GlycanIUPAC_T133 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G10151YZ" | denotes | GlcNAc |
| GlycanIUPAC_T134 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G17585ZM" | denotes | GlcNAc |
| GlycanIUPAC_T135 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G04411CJ" | denotes | GlcNAc |
| GlycanIUPAC_T136 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G38254HJ" | denotes | GlcNAc |
| GlycanIUPAC_T137 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G75188FS" | denotes | GlcNAc |
| GlycanIUPAC_T138 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G70374VG" | denotes | GlcNAc |
| GlycanIUPAC_T139 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G45176LJ" | denotes | GlcNAc |
| GlycanIUPAC_T140 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G30874VW" | denotes | GlcNAc |
| GlycanIUPAC_T141 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G69333MI" | denotes | GlcNAc |
| GlycanIUPAC_T142 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G10676XO" | denotes | GlcNAc |
| GlycanIUPAC_T143 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G14843DJ" | denotes | GlcNAc |
| GlycanIUPAC_T144 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G47546FR" | denotes | GlcNAc |
| GlycanIUPAC_T145 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G73695ZM" | denotes | GlcNAc |
| GlycanIUPAC_T146 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G31923TJ" | denotes | GlcNAc |
| GlycanIUPAC_T147 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G60519EP" | denotes | GlcNAc |
| GlycanIUPAC_T148 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G07933IA" | denotes | GlcNAc |
| GlycanIUPAC_T149 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G40745NH" | denotes | GlcNAc |
| GlycanIUPAC_T150 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G54496YV" | denotes | GlcNAc |
| GlycanIUPAC_T151 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G62953SQ" | denotes | GlcNAc |
| GlycanIUPAC_T152 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G70070AY" | denotes | GlcNAc |
| GlycanIUPAC_T153 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G78792WC" | denotes | GlcNAc |
| GlycanIUPAC_T154 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G25238AV" | denotes | GlcNAc |
| GlycanIUPAC_T155 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G40510DP" | denotes | GlcNAc |
| GlycanIUPAC_T156 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G61120TK" | denotes | GlcNAc |
| GlycanIUPAC_T157 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G41342KV" | denotes | GlcNAc |
| GlycanIUPAC_T158 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G90703NA" | denotes | GlcNAc |
| GlycanIUPAC_T159 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G01591HR" | denotes | GlcNAc |
| GlycanIUPAC_T160 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G56520XN" | denotes | GlcNAc |
| GlycanIUPAC_T161 | 2580-2586 | "http://rdf.glycoinfo.org/glycan/G81830JX" | denotes | GlcNAc |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 54-60 | Glycan | denotes | core-2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
| T2 | 1071-1077 | Glycan | denotes | core-2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 514-532 | Disease | denotes | pancreatic tumoral | http://purl.obolibrary.org/obo/MONDO_0009831|http://purl.obolibrary.org/obo/MONDO_0021040 |
| T3 | 961-979 | Disease | denotes | pancreatic tumoral | http://purl.obolibrary.org/obo/MONDO_0009831|http://purl.obolibrary.org/obo/MONDO_0021040 |
| T5 | 1325-1330 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 514-532 | Phenotype | denotes | pancreatic tumoral | HP:0002894 |
| T2 | 961-979 | Phenotype | denotes | pancreatic tumoral | HP:0002894 |
| T3 | 1325-1330 | Phenotype | denotes | tumor | HP:0002664 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-142 | Sentence | denotes | The formation of the oncofetal J28 glycotope involves core-2 beta6-N-acetylglucosaminyltransferase and alpha3/4-fucosyltransferase activities. |
| T2 | 143-327 | Sentence | denotes | The feto-acinar pancreatic protein or FAPP, the oncofetal glycoisoform of bile salt-dependent lipase (BSDL), is characterized by the presence of the J28 glycotope recognized by mAbJ28. |
| T3 | 328-436 | Sentence | denotes | This fucosylated epitope is carried out by the O-linked glycans of the C-terminal mucin-like region of BSDL. |
| T4 | 437-575 | Sentence | denotes | This glycotope is expressed by human tumoral pancreatic tissues and by human pancreatic tumoral cell lines such as SOJ-6 and BxPC-3 cells. |
| T5 | 576-678 | Sentence | denotes | However, it is not expressed by the normal human pancreatic tissues and by MiaPaCa-2 and Panc-1 cells. |
| T6 | 679-844 | Sentence | denotes | Due to the presence of many putative sites for O-glycosylation on FAPP and BSDL, the structure of the J28 glycotope cannot be attained by classical physical methods. |
| T7 | 845-1132 | Sentence | denotes | In the first part of the present study, we have determined which glycosyltransferases were differently expressed in pancreatic tumoral cell lines compared to normal tissues, focusing in part on fucosyltransferases (Fuc-T) and core-2 beta6-N-acetylglucosaminyltransferase (Core2GlcNAc-T). |
| T8 | 1133-1262 | Sentence | denotes | Our data suggested that alpha2-Fuc-T activity was decreased in the four cell lines tested (SOJ-6, BxPC-3, MiaPaCa-2, and Panc-1). |
| T9 | 1263-1508 | Sentence | denotes | The alpha(1-3) and alpha(1-4) fucosylations were decreased in tumor cells that do not express the J28 glycotope whereas alpha4-Fuc-T and Core2GlcNAc-T activities were significantly increased in SOJ-6 cells which best expressed the J28 glycotope. |
| T10 | 1509-1759 | Sentence | denotes | Therefore, we wished to gain information about glycosyltransferases involved in the building of this structure by transfecting the cDNA encoding the mucin-like region of BSDL in CHO-K1 also expressing Core2GlcNAc-T and/or FUT3 and/or FUT7 activities. |
| T11 | 1760-1873 | Sentence | denotes | These CHO-K1 cells have been previously transfected with the cDNA encoding Core2GlcNAc-T and/or FUT3 and/or FUT7. |
| T12 | 1874-2033 | Sentence | denotes | Data indicated that the C-terminal peptide of BSDL (Cter) produced by those cells did not carry out the J28 glycotope unless Core2GlcNAc-T activity is present. |
| T13 | 2034-2106 | Sentence | denotes | Further transfection with FUT3 cDNA, increased the antibody recognition. |
| T14 | 2107-2236 | Sentence | denotes | Nevertheless, transfection with FUT3 or FUT7 alone did not generate the formation of the J28 glycotope on the C-terminal peptide. |
| T15 | 2237-2419 | Sentence | denotes | Furthermore, the Cter peptide produced by CHO-K1 cells expressing Core2GlcNAc-T was more reactive to the mAbJ28 after in vitro fucosylation with the recombinant soluble form of FUT3. |
| T16 | 2420-2596 | Sentence | denotes | These data suggested that the J28 glycotope encompasses structures initiated by Core2GlcNAc-T and further fucosylated by alpha3/4-Fuc-T such as FUT3, likely on GlcNAc residues. |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 514-532 | Disease | denotes | pancreatic tumoral | MONDO:0021040 |
| T2 | 961-979 | Disease | denotes | pancreatic tumoral | MONDO:0021040 |
| T3 | 1325-1330 | Disease | denotes | tumor | MONDO:0005070 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 468-473 | Organism | denotes | human | 9606 |
| T2 | 508-513 | Organism | denotes | human | 9606 |
| T3 | 619-624 | Organism | denotes | human | 9606 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 217-221 | Body_part | denotes | bile | http://purl.obolibrary.org/obo/UBERON_0001970 |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 217-221 | Body_part | denotes | bile | FMA:62971 |
| T2 | 493-500 | Body_part | denotes | tissues | FMA:9637 |
| T3 | 636-643 | Body_part | denotes | tissues | FMA:9637 |
| T4 | 1010-1017 | Body_part | denotes | tissues | FMA:9637 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 468-473 | OrganismTaxon | denotes | human | 9606 |
| T2 | 508-513 | OrganismTaxon | denotes | human | 9606 |
| T3 | 619-624 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 217-221 | Body_part | denotes | bile | http://purl.obolibrary.org/obo/UBERON_0001970 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 514-532 | Phenotype | denotes | pancreatic tumoral | HP:0002894 |
| T2 | 961-979 | Phenotype | denotes | pancreatic tumoral | HP:0002894 |
| T3 | 1325-1330 | Phenotype | denotes | tumor | HP:0002664 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 525-537 | Cell | denotes | tumoral cell | http://purl.obolibrary.org/obo/CL:0001063 |
| T2 | 972-984 | Cell | denotes | tumoral cell | http://purl.obolibrary.org/obo/CL:0001063 |
| T3 | 1325-1336 | Cell | denotes | tumor cells | http://purl.obolibrary.org/obo/CL:0001063 |